Physician

Jennifer Rae Elliott, MD

According to 2025 Medicare claims, Jennifer Elliott, MD (NPI: 1093823437) practices rheumatology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is RHEUMATOLOGY & OSTEOPOROSIS SERVICES, P.C. (NPI: 1174737597; TIN: 201212442) and primary practice location at 68510-2466. Elliott is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), Aledade 149 Regional MSSP (ACO ID: A5231), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Elliott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 182,097 HCPCS/CPT codes, and received $1,432,190 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 961 prescription claims across 194 beneficiaries totaling $206,685 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $91,967 to $1,432,190. In contrast, Part D prescription costs have fallen sharply in recent years, from $451,469 to $206,685. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	381	2,852	$91,967
2016	411	9,091	$130,437
2017	339	9,630	$118,876
2018	411	5,880	$105,015
2019	439	11,318	$157,763
2020	464	10,781	$148,916
2021	433	11,015	$152,248
2022	364	25,729	$235,338
2023	462	107,273	$861,879
2024	549	182,097	$1,432,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	295	2,402	$451,469
2016	325	2,909	$611,535
2017	286	2,241	$874,087
2018	236	1,705	$898,477
2019	262	1,890	$975,245
2020	267	1,646	$836,132
2021	271	1,422	$700,485
2022	261	1,248	$510,380
2023	208	847	$213,546
2024	194	961	$206,685

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	178	250	$83
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	102	368	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	211	328	$11
96372	Injection of drug or substance under skin or into muscle	126	290	$10
J3111	Injection, romosozumab-aqqg, 1 mg	117	58,800	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	13	364	$93,443
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	254	13,656	$9,099
Mycophenolate Mofetil	Mycophenolate Mofetil	49	2,130	$4,628
Duloxetine Hcl	Duloxetine Hcl	179	8,791	$4,193
Mycophenolic Acid	Mycophenolate Sodium	12	360	$2,463

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$17	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jennifer Rae Elliott, MD?

Tedicare shows public-source Medicare data for Jennifer Rae Elliott, MD (NPI 1093823437), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer Rae Elliott, MD have ACO affiliation data?

Jennifer Rae Elliott, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Aledade 149 Regional MSSP (MSSP, ACO ID A5231), and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Jennifer Rae Elliott, MD?

Jennifer Rae Elliott, MD is linked to RHEUMATOLOGY & OSTEOPOROSIS SERVICES, P.C. (billing NPI 1174737597) in the available physician profile data.

Does Jennifer Rae Elliott, MD have Open Payments data?

Jennifer Rae Elliott, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.